Tekla Capital Management’s TScan Therapeutics TCRX Stock Holding History

Tekla Capital Management’s Portfolio TCRX Stock Details TCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$500K	Hold
2023 Q1	$420K	Hold
2022 Q4	$326K	Hold
2022 Q3	$610K	Hold
2022 Q2	$629K	Hold
2022 Q1	$560K	Hold
2021 Q4	$900K	Hold
2021 Q3	$1.67M	Buy